Clinical application of ultrasound-guided percutaneous gastrostomy in esophageal cancer with malignant stenosis
10.3760/cma.j.cn115355-20240806-00383
- VernacularTitle:超声引导下经皮胃造瘘术在食管癌恶性狭窄中的临床应用
- Author:
Jie LI
1
;
Shuai LIN
;
Xiaopeng LI
Author Information
1. 西安交通大学第二附属医院医用超声研究室，西安 710004
- Publication Type:Journal Article
- Keywords:
Esophageal neoplasms;
Esophageal stenosis;
Ultrasound-guided;
Gastrostomy
- From:
Cancer Research and Clinic
2025;37(9):667-671
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To explore the clinical application effect of ultrasound-guided percutaneous gastrostomy in esophageal cancer with malignant stenosis.Methods:A retrospective case series study was conducted. Forty patients with malignant esophageal stenosis caused by esophageal cancer who were admitted to the Second Affiliated Hospital of Xi'an Jiaotong University from September 2020 to December 2021 were selected. All patients underwent ultrasound-guided percutaneous gastrostomy, and the surgical effect and postoperative complications were evaluated. The nutritional and immune index levels and quality of life improvement of patients before and after gastrostomy were compared.Results:Forty patients were aged (68±10) years, including 31 males and 9 females. The success rate of gastrostomy was 92.5% (37/40), and the incidence of postoperative complications such as abdominal fluid leakage and wound bleeding was 8.1% (3/37). There were no early deaths in patients. Thirty days after gastrostomy, the serum albumin, hemoglobin, serum prealbumin, body mass index, and quality of life score of patients were all higher than those before surgery, the physical status score of Eastern Cancer Collaboration Group was lower than that before surgery, and the differences were statistically significant (all P < 0.001); the postoperative lymphocyte count showed an increasing trend, but the difference was not statistically significant ( P > 0.05). Conclusions:Ultrasound-guided percutaneous gastrostomy has low trauma and high success rate, which can improve the nutritional status and quality of life of patients with malignant esophageal stenosis and enhance their immunity.
